WallStSmart

Moving iMage Technologies Inc (MITQ)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 1275% more annual revenue ($258.90M vs $18.83M). MITQ leads profitability with a -1.5% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

MITQ

Avoid

34

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 6.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MITQUndervalued (+86.8%)

Margin of Safety

+86.8%

Fair Value

$5.14

Current Price

$0.64

$4.50 discount

UndervaluedFair: $5.14Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MITQ1 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

MITQ4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$6.84M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-5.4%2/10

ROE of -5.4% — below average capital efficiency

Free Cash FlowQuality
$-1.64M2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : MITQ

The strongest argument for MITQ centers on Price/Book. Revenue growth of 10.2% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : MITQ

The primary concerns for MITQ are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

MITQ profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor COMMUNICATION EQUIPMENT industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 34/100) and 43.0% revenue growth. MITQ offers better value entry with a 86.8% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Moving iMage Technologies Inc

TECHNOLOGY · COMMUNICATION EQUIPMENT · USA

Moving iMage Technologies Inc. (MITQ) is a leading technology innovator transforming the cinema industry through state-of-the-art digital solutions that significantly enhance the movie-going experience. The company's diverse offerings, including advanced digital signage and immersive cinema technologies, are strategically designed to improve operational efficiency and boost audience engagement. As theaters adapt to the evolving landscape following the pandemic, MITQ stands out as a key partner capable of driving success in content delivery and consumer interactions. With a robust focus on innovation and customer satisfaction, MITQ presents an attractive growth opportunity within a recovering entertainment sector.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?